Your browser doesn't support javascript.
loading
Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey.
Hüls, Anke; Costa, Alberto C S; Dierssen, Mara; Baksh, R Asaad; Bargagna, Stefania; Baumer, Nicole T; Brandão, Ana Claudia; Carfi, Angelo; Carmona-Iragui, Maria; Chicoine, Brian Allen; Ghosh, Sujay; Lakhanpaul, Monica; Manso, Coral; Mayer, Miguel-Angel; Ortega, Maria Del Carmen; de Asua, Diego Real; Rebillat, Anne-Sophie; Russell, Lauren Ashley; Sgandurra, Giuseppina; Valentini, Diletta; Sherman, Stephanie L; Strydom, Andre.
Afiliação
  • Hüls A; Department of Epidemiology and Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  • Costa ACS; Departments of Pediatrics and of Psychiatry, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
  • Dierssen M; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Baksh RA; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Bargagna S; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain.
  • Baumer NT; Institute of Psychiatry, Psychology, and Neuroscience, Department of Forensic and Neurodevelopmental Sciences, King's College London, London, United Kingdom.
  • Brandão AC; The London Down Syndrome (LonDownS) Consortium, London, United Kingdom.
  • Carfi A; Fondazione Stella Maris IRCCS, Pisa, Italy.
  • Carmona-Iragui M; Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
  • Chicoine BA; Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil.
  • Ghosh S; Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Lakhanpaul M; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Manso C; Barcelona Down Medical Center, Fundació Catalana de Síndrome de Down, Barcelona, Spain.
  • Mayer MA; Advocate Medical Group Adult Down Syndrome Center, Park Ridge, IL, USA.
  • Ortega MDC; Cytogenetics and Genomics Reserach Unit. Department of Zoology, University of Calcutta.Kolkata. West Bengal, India.
  • de Asua DR; UCL- Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Rebillat AS; Whttington NHS Trust, London, United Kingdom; Down Syndrome Medical Interest Group, London, United Kingdom.
  • Russell LA; CM: DOWN ESPAÑA, Madrid, Spain.
  • Sgandurra G; Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute and DCEXS Universitat Pompeu Fabra, Barcelona, Spain.
  • Valentini D; Department of Psychiatry, Research Institute i+12. Hospital Universitario 12 de Octubre. Madrid, Spain.
  • Sherman SL; Department of Internal Medicine and Instituto de Investigación Biomédica-La Princesa, Hospital Universitario de La Princesa, Madrid, Spain.
  • Strydom A; Institut Jérôme Lejeune, Paris, France.
EClinicalMedicine ; 33: 100769, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33644721
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article